SEC Form SC 13D/A filed by New Ireland Fund, Inc. (The) (Amendment)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No.2)*

New Ireland Fund, Inc

(Name of Issuer)

Common Shares, $0.01 par value

(Title of Class of Securities)

645673104

(CUSIP Number)

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

December 13, 2021

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 6 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

The percentages used herein are calculated based upon 3,639,902 shares of common stock outstanding as of 5/13/21, as disclosed in the company's N-CSRS filed 6/30/21

The percentages used herein are calculated based upon 3,639,902 shares of common stock outstanding as of 5/13/21, as disclosed in the company's N-CSRS filed 6/30/21

The percentages used herein are calculated based upon 3,639,902 shares of common stock outstanding as of 5/13/21, as disclosed in the company's N-CSRS filed 6/30/21

This Amendment No. 2 amends and supplements the statement on Schedule 13D filed with the SEC on 11/10/21; as amended by Amendment No. 1 filed 12/10/21, with respect to the common shares of New Ireland Fund, Inc.  This Amendment No. 2 amends Item 4, as set forth below.

Item 4. PURPOSE OF TRANSACTION

Item 4 is hereby amended and supplemented as follows:

On December 13, 2021, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital Management, L.P., submitted to the Issuer a notice informing the Issuer of its intention to nominate Paul Kazarian for election to the Issuer's board of directors at the Issuer's 2022 annual meeting of shareholders.

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date:  December 14, 2021